Junli He - Apr 10, 2023 Form 4/A - Amendment Insider Report for Biostage, Inc. (BSTG)

Signature
/s/ Joseph Damasio, by power of attorney
Stock symbol
BSTG
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/10/2023, 03:47 PM
Date Of Original Report
Apr 12, 2023
Previous filing
Jan 5, 2023
Next filing
Aug 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Stock Option (right to buy) Award $0 +268K $0.00 268K Apr 10, 2023 Common Stock, par value $0.01 per share 268K $6.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.